Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Topics:
Hematologic Malignancies
•
Medical Oncology
•
Lymphoma
•
Hematology
In a young fit patient with cardiac dysfunction and mild neuropathy, what would you use as first-line therapy for CD 30+ T cell lymphoma?
Is there any data for brentuximab with a chemo backbone that does not include adriamycin?
Related Questions
How should community oncologists practically counsel patients with aggressive lymphomas on the potential treatment course as they move into 2L/3L therapies?
What is the optimal choice of therapy for a patient with Hodgkin variant of Richter's transformation from underlying CLL/SLL?
What is your treatment approach to newly diagnosed primary effusion lymphoma?
Following the BRUIN data in mantle cell lymphoma, will you routinely treat with pirtobrutinib following a covalent BTKi?
How do you decide between treatment with ABVD vs A + AVD in a patient in their 70s with advanced stage 4 classical Hodgkin lymphoma?
When would you consider treating an asymptomatic patient with follicular lymphoma?
How do you manage grade 1-3A Follicle Center Lymphoma of the lower female genital tract, presenting with a cervical mass?
How would you manage a patient with p53 mutated MCL who has progressed after a BTKi and CAR-T with a CD20 negative clone?
How are you deciding between available third line therapies for post-transplant relapsed DLBCL?
What are your practical considerations for incorporating bispecific antibody therapy into treatment of relapsed DLBCL?